Agency Header

DUR Newsletters

A quarterly newsletter, DUR Capsules, is published by the BMS Pharmacy Program in conjunction with the DUR vendor for prescribers and pharmacy providers.  This letter provides information on a number of topics of interest including current clinical drug information and Bureau policy updates. 

2013 Newsletters
Preferred Drug List Updates December, 2013
Focus on Atypical Antipsychotics February, 2013

2012 Newsletters
Incretin-Based Therapies in the Management of Type 2 Diabetes November, 2012
New Oral Anticoagutiants June, 2012
Treatment of Attention-Deficit/Hyperactivity Disorder April, 2012

2011 Newsletters
Bacterial Conjunctivitis November, 2011
New Prescribing Recommendations for Simvastatin June, 2011

2010 Newsletters
Considerations when Using Controlled Substances to Treat Chronic Pain
DUR Capsules - Prior Authorization of Suboxone® or Subutex® Spring, 2010